Overview
Paris-based biotech startup spore.bio has raised €29.9 million ($35 million) in funding, including multi-million-euro support from the google.org fund for AI in science. The company addresses challenges in microbiology testing with its AI-powered technology, which provides immediate, on-site analysis of microbial activity, significantly reducing traditional testing times. Spore.bio is the only startup globally selected by the google.org fund for this initiative, and it plans to expand its research division, spore.labs, to further enhance public health solutions.
Products
Loading...
Recent Deals
Investors: google.org
Paris-based biotech startup spore.bio has raised €29.9 million ($35 million) in funding, including multi-million-euro support from the google.org fund for AI in science. The company addresses challenges in microbiology testing with its AI-powered technology, which provides immediate, on-site analysis of microbial activity, significantly reducing traditional testing times. Spore.bio is the only startup globally selected by the google.org fund for this initiative, and it plans to expand its research division, spore.labs, to further enhance public health solutions.